---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-009882"
form_type: "8-K"
ticker: "SYRA"
cik: "0001922335"
company_name: "Syra Health Corp"
filed_at: "2025-03-11T23:59:59+00:00"
generated_at: "2026-05-25T00:07:57.218465+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Syra Health FY 2024 revenue $8.0M (+45% YoY); Q4 net loss nearly halved to $504K; PopHealth up 132%

## Summary
- FY 2024 revenue $8.0M (+45% YoY); net loss $3.8M vs $2.9M in 2023.
- Q4 2024 revenue $2.0M (+14% YoY); net loss $504K vs $995K (halved YoY).
- Population Health revenue $1.7M in 2024 (+132% YoY); Q4 PopHealth up 285% YoY.
- Cash $2.4M, no long-term debt; 2025 guidance low double-digit % revenue growth.
- Secured contract extensions: Indiana $1.5M, Tennessee $450K (up to $1.3M), DC $1M.

## SEC filing metadata
- accession: 0001493152-25-009882
- form_type: 8-K
- ticker: SYRA
- cik: 0001922335
- company_name: Syra Health Corp
- filed_at: 2025-03-11T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1922335/000149315225009882/0001493152-25-009882-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1922335/000149315225009882/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-009882
- JSON: https://secwatch.observer/filing/0001493152-25-009882.json
- Plain text: https://secwatch.observer/filing/0001493152-25-009882.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.